Clinicopathological features and treatment outcome of central neurocytoma: a single institute experience

Table 2 Treatment outcome

Outcome	N (total n = 17)	%
Alive
Yes	17	100
No	0	0
Recurrence rate
No recurrence	13	76.5
Recurrence^a	4	23.5
5-year progression free survival	70 ± 13%
Median time to progression (months)	39 (11–48)

^aTwo patients had 1 recurrence, 1 patient had 2 recurrences and 1 patient had 3 recurrences